Effect of iron sucrose on human peritoneal mesothelial cells

被引:13
作者
Brèborowicz, M
Polubinska, A
Tam, P
Wu, G
Brèborowicz, A
机构
[1] Poznan Med Sch, Dept Pathophysiol, PL-60781 Poznan, Poland
[2] Inst Kidney Lifesci Technol, Toronto, ON, Canada
关键词
biocompatibility; free radicals; iron sucrose; mesothelial cells;
D O I
10.1111/j.1365-2362.2003.01264.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Iron supplementation is often required in uraemic patients with anaemia. Peritoneal cavity was proposed as an alternative intravenous route for iron infusion in patients treated with peritoneal dialysis. We studied the effect of iron sucrose (Venofer((R))) on the function of human peritoneal mesothelial cells maintained in in vitro culture. Materials and methods In in vitro experiments on human peritoneal, the mesothelial effect of elemental iron (in conc. 0.0001-1 mg mL(-1)) present in Venofer((R)) on their viability, growth and synthesis of IL-6 was studied. Additionally we evaluated with a fluorescent probe (2',7'-dichlorodihydro-fluorescein diacatate) generation of reactive oxygen species in cells exposed to iron sucrose. We also measured accumulation of iron in the cytoplasm of mesothelial cells after their in vitro exposure to Venofer((R)). Results In in vitro conditions iron induces a dose-dependent inhibition of viability of the mesothelial cells as reflected by inhibition of the cells growth by 34% at Fe 0.1 mg mL(-1) vs. control (P < 0.05) increased release of lactate dehydrogenase (LDH) from the cytosol: 67.1 +/- 30.3 mU mL(-1) at Fe 1 mg mL(-1) vs. 7.9 +/- 6.4 in control group (P < 0.001), and reduced synthesis of IL-6: 209 +/- 378 pg mg(-1) cell protein at Fe 1 mg mL(-1) vs. 38674 +/- 4146 pg mg(-1) cell protein in controls (P < 0.001). Cytotoxicity of iron towards mesothelial cells was enhanced in vitro when it was tested in presence of the dialysis fluid. Iron used in vitro at concentration 0.0001 mg mL(-1) and greater induces generation of oxygen-derived free radicals in mesothelial cells. Furthermore, iron is taken by these cells and stored in their cytosol, resulting in stimulation of the intracellular generation of free radicals. Conclusions We conclude that iron used in the form of iron sucrose is cytotoxic to human peritoneal mesothelial cells. Accumulation of iron sucrose within cytoplasm of these cells may lead to induction of its chronic cytotoxic effect.
引用
收藏
页码:1038 / 1044
页数:7
相关论文
共 24 条
  • [11] Mars RL, 1999, ADV PERIT D, V15, P60
  • [12] NISSENON AR, 1999, KIDNEY INT S, V99, pS18
  • [13] Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American clinical trial
    Nissenson, AR
    Lindsay, RM
    Swan, S
    Seligman, P
    Strobos, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (03) : 471 - 482
  • [14] INDUCTION OF MESOTHELIOMA BY INTRAPERITONEAL INJECTIONS OF FERRIC SACCHARATE IN MALE WISTAR RATS
    OKADA, S
    HAMAZAKI, S
    TOYOKUNI, S
    MIDORIKAWA, O
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (05) : 708 - 711
  • [15] Park SE, 1997, PERITON DIALYSIS INT, V17, P179
  • [16] Pecoits-Filho RFS, 1998, PERITON DIALYSIS INT, V18, P64
  • [17] Chronic peritoneal dialysis in iron-deficient rats with solutions containing iron dextran
    Reddy, DK
    Moore, HL
    Lee, JH
    Saran, R
    Nolph, KD
    Khanna, R
    Twardowski, ZJ
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (02) : 764 - 773
  • [18] Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo
    Rooyakkers, TM
    Stroes, ESG
    Kooistra, MP
    van Faassen, EE
    Hider, RC
    Rabelink, TJ
    Marx, JJM
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 : 9 - 16
  • [19] Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure:: links to inflammation and oxidative stress
    Stenvinkel, P
    Bárány, P
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 : 32 - 37
  • [20] Comparative look at intravenous iron agents:: Pharmacology, efficacy, and safety of iron dextran, iron saccharate, and ferric gluconate
    Sunder-Plassmann, G
    Hörl, WH
    [J]. SEMINARS IN DIALYSIS, 1999, 12 (04) : 243 - 248